课题基金 / 基金详情

PHASE I/II STUDY OF SAFETY/TOLERANCE/PK/ANTIVIRIAL ACTIVITY OF DMPA IN HIV

PHASE I/II STUDY OF SAFETY/TOLERANCE/PK/ANTIVIRIAL ACTIVITY OF DMPA IN HIV
DMPA 在 HIV 中的安全性/耐受性/药代动力学/抗病毒活性的 I/II 期研究
批准号:
6115465
负责人:
STEVEN Grant DEEKS
金额:
$3.1万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

STEVEN Grant DEEKS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a phase I/II study evaluating the safety, pharmacokinetics and efficacy of PMPA in HIV-1 infected patients. PMPA is a novel nucleotide analog which has been shown to be very potent in animal models. PMPA will be infused over 30 minutes. Extensive pharmacokinetic, safety and viral RNA sampling will be done during 2 weeks of study and 4 weeks of follow- up.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Delaney AIDS Research Enterprise to Cure HIV
Delaney AIDS Research Enterprise to Cure HIV
Delaney AIDS Research Enterprise to Cure HIV
Therapeutic vaccination and PD-1 blockade in treated HIV disease
海外基金